Neurological Biomarkers Market Report

Global and Region Neurological Biomarkers Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Aug 01, 2022
  • PAGES：199
  • REPORT CODE：GMM976980
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Neurological Biomarkers market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Neurological Biomarkersmarket, defines the market attractiveness level of Neurological Biomarkers market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Neurological Biomarkers industry, describes the types of Neurological Biomarkers market, the applications of major players and the market size, and deeply analyzes the current situation of the global Neurological Biomarkers market and the development prospects and opportunities of Neurological Biomarkers industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Neurological Biomarkers market in Chapter 13.

    By Player:

    • AbaStar MDx, Inc

    • QIAGEN

    • Acumen Pharmaceuticals

    • Athena Diagnostics

    • Alseres Pharmaceuticals, Inc

    • Bio-Rad Laboratories, Inc

    • Thermo Fisher Scientific Inc

    • Myriad RBM

    • BANYAN BIOMARKERS, INC

    • Abbott

    By Type:

    • Metabolomic

    • Genomic

    • Proteomic

    • Imaging

    • Others

    By End-User:

    • Research Organizations

    • Hospital Laboratories

    • Independent Clinical Diagnostic Centers

    • Others

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Neurological Biomarkers Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Neurological Biomarkers Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Neurological Biomarkers Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Neurological Biomarkers Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Neurological Biomarkers Market Analysis and Outlook to 2022

    • 7.1 Global Neurological Biomarkers Consumption (2017-2022)

    • 7.2 United States Neurological Biomarkers Consumption (2017-2022)

    • 7.3 Europe Neurological Biomarkers Consumption (2017-2022)

    • 7.4 China Neurological Biomarkers Consumption (2017-2022)

    • 7.5 Japan Neurological Biomarkers Consumption (2017-2022)

    • 7.6 India Neurological Biomarkers Consumption (2017-2022)

    • 7.7 South Korea Neurological Biomarkers Consumption (2017-2022)

    8 Region and Country-wise Neurological Biomarkers Market Analysis and Outlook to 2028

    • 8.1 Global Neurological Biomarkers Consumption Forecast (2022-2028)

    • 8.2 United States Neurological Biomarkers Consumption Forecast (2022-2028)

    • 8.3 Europe Neurological Biomarkers Consumption Forecast (2022-2028)

    • 8.4 China Neurological Biomarkers Consumption Forecast (2022-2028)

    • 8.5 Japan Neurological Biomarkers Consumption Forecast (2022-2028)

    • 8.6 India Neurological Biomarkers Consumption Forecast (2022-2028)

    • 8.7 South Korea Neurological Biomarkers Consumption Forecast (2022-2028)

    9 Global Neurological Biomarkers Market Outlook by Types and Applications to 2022

    • 9.1 Global Neurological Biomarkers Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Metabolomic Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Genomic Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Proteomic Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Imaging Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global Others Consumption and Growth Rate (2017-2022)

    • 9.2 Global Neurological Biomarkers Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Research Organizations Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Hospital Laboratories Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Independent Clinical Diagnostic Centers Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Others Consumption and Growth Rate (2017-2022)

    10 Global Neurological Biomarkers Market Outlook by Types and Applications to 2028

    • 10.1 Global Neurological Biomarkers Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Metabolomic Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Genomic Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Proteomic Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global Imaging Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.5 Global Others Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Neurological Biomarkers Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Research Organizations Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Hospital Laboratories Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Independent Clinical Diagnostic Centers Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.4 Global Others Consumption Forecast and Growth Rate (2022-2028)

    11 Global Neurological Biomarkers Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Neurological Biomarkers Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Neurological Biomarkers Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Neurological Biomarkers Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Neurological Biomarkers Market Competitive Analysis

    • 14.1 AbaStar MDx, Inc

      • 14.1.1 AbaStar MDx, Inc Company Details

      • 14.1.2 AbaStar MDx, Inc Neurological Biomarkers Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 AbaStar MDx, Inc Neurological Biomarkers Product and Service

    • 14.2 QIAGEN

      • 14.2.1 QIAGEN Company Details

      • 14.2.2 QIAGEN Neurological Biomarkers Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 QIAGEN Neurological Biomarkers Product and Service

    • 14.3 Acumen Pharmaceuticals

      • 14.3.1 Acumen Pharmaceuticals Company Details

      • 14.3.2 Acumen Pharmaceuticals Neurological Biomarkers Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Acumen Pharmaceuticals Neurological Biomarkers Product and Service

    • 14.4 Athena Diagnostics

      • 14.4.1 Athena Diagnostics Company Details

      • 14.4.2 Athena Diagnostics Neurological Biomarkers Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Athena Diagnostics Neurological Biomarkers Product and Service

    • 14.5 Alseres Pharmaceuticals, Inc

      • 14.5.1 Alseres Pharmaceuticals, Inc Company Details

      • 14.5.2 Alseres Pharmaceuticals, Inc Neurological Biomarkers Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Alseres Pharmaceuticals, Inc Neurological Biomarkers Product and Service

    • 14.6 Bio-Rad Laboratories, Inc

      • 14.6.1 Bio-Rad Laboratories, Inc Company Details

      • 14.6.2 Bio-Rad Laboratories, Inc Neurological Biomarkers Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Bio-Rad Laboratories, Inc Neurological Biomarkers Product and Service

    • 14.7 Thermo Fisher Scientific Inc

      • 14.7.1 Thermo Fisher Scientific Inc Company Details

      • 14.7.2 Thermo Fisher Scientific Inc Neurological Biomarkers Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Thermo Fisher Scientific Inc Neurological Biomarkers Product and Service

    • 14.8 Myriad RBM

      • 14.8.1 Myriad RBM Company Details

      • 14.8.2 Myriad RBM Neurological Biomarkers Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Myriad RBM Neurological Biomarkers Product and Service

    • 14.9 BANYAN BIOMARKERS, INC

      • 14.9.1 BANYAN BIOMARKERS, INC Company Details

      • 14.9.2 BANYAN BIOMARKERS, INC Neurological Biomarkers Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 BANYAN BIOMARKERS, INC Neurological Biomarkers Product and Service

    • 14.10 Abbott

      • 14.10.1 Abbott Company Details

      • 14.10.2 Abbott Neurological Biomarkers Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Abbott Neurological Biomarkers Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Neurological Biomarkers

    • Figure Neurological Biomarkers Picture

    • Table Global Neurological Biomarkers Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Neurological Biomarkers Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Neurological Biomarkers Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Neurological Biomarkers Consumption by Country (2017-2022)

    • Figure United States Neurological Biomarkers Consumption and Growth Rate (2017-2022)

    • Table Europe Neurological Biomarkers Consumption and Growth Rate (2017-2022)

    • Figure China Neurological Biomarkers Consumption and Growth Rate (2017-2022)

    • Figure Japan Neurological Biomarkers Consumption and Growth Rate (2017-2022)

    • Figure India Neurological Biomarkers Consumption and Growth Rate (2017-2022)

    • Figure South Korea Neurological Biomarkers Consumption and Growth Rate (2017-2022)

    • Figure Global Neurological Biomarkers Consumption Forecast by Country (2022-2028)

    • Figure United States Neurological Biomarkers Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Neurological Biomarkers Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Neurological Biomarkers Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Neurological Biomarkers Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Neurological Biomarkers Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Neurological Biomarkers Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Metabolomic Consumption and Growth Rate (2017-2022)

    • Figure Global Genomic Consumption and Growth Rate (2017-2022)

    • Figure Global Proteomic Consumption and Growth Rate (2017-2022)

    • Figure Global Imaging Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Research Organizations Consumption and Growth Rate (2017-2022)

    • Figure Global Hospital Laboratories Consumption and Growth Rate (2017-2022)

    • Figure Global Independent Clinical Diagnostic Centers Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Metabolomic Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Genomic Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Proteomic Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Imaging Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Research Organizations Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospital Laboratories Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Independent Clinical Diagnostic Centers Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Neurological Biomarkers Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Neurological Biomarkers Export by Region (Top 5 Countries) (2017-2028)

    • Table AbaStar MDx, Inc (Foundation Year, Company Profile and etc.)

    • Table AbaStar MDx, Inc Neurological Biomarkers Sales, Price, Value and Gross Profit (2017-2022)

    • Table AbaStar MDx, Inc Neurological Biomarkers Product and Service

    • Table QIAGEN (Foundation Year, Company Profile and etc.)

    • Table QIAGEN Neurological Biomarkers Sales, Price, Value and Gross Profit (2017-2022)

    • Table QIAGEN Neurological Biomarkers Product and Service

    • Table Acumen Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Acumen Pharmaceuticals Neurological Biomarkers Sales, Price, Value and Gross Profit (2017-2022)

    • Table Acumen Pharmaceuticals Neurological Biomarkers Product and Service

    • Table Athena Diagnostics (Foundation Year, Company Profile and etc.)

    • Table Athena Diagnostics Neurological Biomarkers Sales, Price, Value and Gross Profit (2017-2022)

    • Table Athena Diagnostics Neurological Biomarkers Product and Service

    • Table Alseres Pharmaceuticals, Inc (Foundation Year, Company Profile and etc.)

    • Table Alseres Pharmaceuticals, Inc Neurological Biomarkers Sales, Price, Value and Gross Profit (2017-2022)

    • Table Alseres Pharmaceuticals, Inc Neurological Biomarkers Product and Service

    • Table Bio-Rad Laboratories, Inc (Foundation Year, Company Profile and etc.)

    • Table Bio-Rad Laboratories, Inc Neurological Biomarkers Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bio-Rad Laboratories, Inc Neurological Biomarkers Product and Service

    • Table Thermo Fisher Scientific Inc (Foundation Year, Company Profile and etc.)

    • Table Thermo Fisher Scientific Inc Neurological Biomarkers Sales, Price, Value and Gross Profit (2017-2022)

    • Table Thermo Fisher Scientific Inc Neurological Biomarkers Product and Service

    • Table Myriad RBM (Foundation Year, Company Profile and etc.)

    • Table Myriad RBM Neurological Biomarkers Sales, Price, Value and Gross Profit (2017-2022)

    • Table Myriad RBM Neurological Biomarkers Product and Service

    • Table BANYAN BIOMARKERS, INC (Foundation Year, Company Profile and etc.)

    • Table BANYAN BIOMARKERS, INC Neurological Biomarkers Sales, Price, Value and Gross Profit (2017-2022)

    • Table BANYAN BIOMARKERS, INC Neurological Biomarkers Product and Service

    • Table Abbott (Foundation Year, Company Profile and etc.)

    • Table Abbott Neurological Biomarkers Sales, Price, Value and Gross Profit (2017-2022)

    • Table Abbott Neurological Biomarkers Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US